Table 3.
Interrater reliability study
| A. Demographic and clinical data | |
|---|---|
| Age at visit (mean ± SD) | 52.3 ± 12.0 |
| Sex (male:famale) | 21:19 |
| Education in years (mean ± SD) | 15.6 ± 2.0 |
| Race | 100% white |
| Diagnosis | N (%) |
| CN | 20 (50.0%) |
| MCl-beh, | 4 (10.0%) |
| MCl-cog | 5 (12.5%) |
| bvFTD | 8 (20.0%) |
| nfyPPA | 1 (2.5%) |
| AD | 1 (2.5%) |
| ALS | 1 (2.5%) |
| B. Weighted kappa and ICC statistics | |||
|---|---|---|---|
| Description | Estimate | Lower 95% CL | Upper 95% CL |
| Weighted Kappa for global CDR plus NACC FTLD | 0.842 | 0.723 | 0.960 |
| Weighted Kappa for global CDR | 0.843 | 0.715 | 0.971 |
| ICC for CDR plus NACC FTLD sum of boxes | 0.947 | 0.873 | 0.983 |
| ICC for CDR sum of boxes | 0.945 | 0.855 | 0.983 |
Abbreviation: AD, Alzheimer’s disease; bvFTD, behavioral variant frontotemporal dementia; CL, confidence level; ICC, intraclass correlation; MCI‐beh, mild behavioral change; MCI‐cog, mild cognitive impairment; nfvPPA, non‐fluent/agrammatic variant primary progressive aphasia.